They warn about counterfeit drugs for breast cancer and HIV

The Federal Commission for the Protection against Sanitary Risks (Cofepris) alerts the population about the falsification of three inputs that represent a risk to public health. It is a medication for the care of patients with breast cancer; a treatment for people diagnosed with HIV and a general anesthetic.

The Roche Products company reported that batches B2801, with an expiration date of July 8, 2023, are false, as well as batch B1019 and an expiration date of April 20, 2023, of the product Kadcyla (trastuzumab emtansine), in a 100mg bottle presentation.

Among the irregularities they show is the code 10185236 MX, which It is located at the top of the label; In addition, the liquid has a yellowish color at the time of preparation.

The federal agency announced that the Stribild product (elvitegravir, cobicistat, emtricitabine, tenofovir) with batch ZBXB, shows the expiration dates of November 25, 2023 and February 25, 2025, which are false.

It should be noted that, since November 20, 2020, the company that owns the health registration requested Cofepris to revoke the health registration, making it illegal to market these batches and any other, regardless of the expiration date they show. .

The anesthetic Anesket ketamine was also counterfeited. The presentations with irregularities are: 50mg/mL vial, with lot C21G904, of which It was detected that the expiration date does not belong to the one authorized in the health record; Furthermore, the typography and printing do not correspond to the original product. Likewise, the presentation of 100 mg/mL, lot 2113470 and expiration 11-2026 is not authorized, so its irregularity was determined.

Cofepris recommends that citizens not purchase any of the products with the aforementioned characteristics, since being irregular they do not Their safety, quality and effectiveness are guaranteed and they represent a health risk.since the manufacturing, storage and distribution conditions, as well as the origin of its ingredients, are unknown.

If any adverse reaction or discomfort occurs due to the supply of these products, affected people can file a report by email: [email protected]

They urged those who have information about the illegal sale of these and other health supplies to file a health complaint through gob.mx/cofepris or at the Comprehensive Service Centers that are located in the 32 states of the Mexican Republic.